Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Nisin is a polycyclic antibacterial peptide (a type of bacteriocin) produced by the bacterium Lactococcus lactis. It has been extensively used in the food industry as a natural preservative due to its ability to inhibit the growth of a wide range of Gram-positive bacteria, including Staphylococcus aureus, Listeria monocytogenes, and Bacillus species. The mechanism of action involves binding to lipid II, an essential component in bacterial cell wall synthesis, leading to pore formation and cell death.

While nisin's antimicrobial activity is well documented and validated in food safety applications, its use as a treatment for infections in humans is less established. Some in vitro and animal studies have demonstrated nisin's efficacy against certain drug-resistant bacteria. For example, research has shown nisin is effective in reducing biofilm formation and killing methicillin-resistant Staphylococcus aureus (MRSA) in laboratory settings. Preliminary animal studies have also indicated potential for treating infections such as skin abscesses. However, clinical trials in humans are limited, and nisin is not currently approved as a therapeutic agent for bacterial infections in humans.

In summary, there is scientific validation for nisin’s antibacterial properties, particularly in food preservation and in laboratory models of infection. However, the evidence supporting its direct use for treating bacterial infections in humans is still limited to preclinical research, and further clinical studies are needed to establish safety and efficacy in medical settings.

More about Nisin
More about Infection (bacterial)

Other ingredients used for Infection (bacterial)

Other health conditions supported by Nisin

Products containing Nisin